These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


291 related items for PubMed ID: 9737803

  • 21. Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection.
    Pettis RJ, Ginsberg B, Hirsch L, Sutter D, Keith S, McVey E, Harvey NG, Hompesch M, Nosek L, Kapitza C, Heinemann L.
    Diabetes Technol Ther; 2011 Apr; 13(4):435-42. PubMed ID: 21355718
    [Abstract] [Full Text] [Related]

  • 22. Intramuscular injection of insulin lispro or soluble human insulin: pharmacokinetics and glucodynamics in Type 2 diabetes.
    Milicevic Z, Profozic V, Wyatt J, Ristic S, Woodworth JR, Seger M, Kaliterna D, Bates P, Metelko Z.
    Diabet Med; 2001 Jul; 18(7):562-6. PubMed ID: 11553186
    [Abstract] [Full Text] [Related]

  • 23. [From the concept of fast acting analogs to the properties of the insulin Lispro].
    Selam JL.
    Diabetes Metab; 1997 Sep; 23 Suppl 3():45-9. PubMed ID: 9410552
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics of the rapid-acting insulin analog, insulin aspart, in rats, dogs, and pigs, and pharmacodynamics of insulin aspart in pigs.
    Plum A, Agerso H, Andersen L.
    Drug Metab Dispos; 2000 Feb; 28(2):155-60. PubMed ID: 10640512
    [Abstract] [Full Text] [Related]

  • 25. Technosphere/Insulin--proof of concept study with a new insulin formulation for pulmonary delivery.
    Steiner S, Pfützner A, Wilson BR, Harzer O, Heinemann L, Rave K.
    Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):17-21. PubMed ID: 11835120
    [Abstract] [Full Text] [Related]

  • 26. Smoking enhances absorption of insulin but reduces glucodynamic effects in individuals using the Lilly-Dura inhaled insulin system.
    Wise S, Chien J, Yeo K, Richardson C.
    Diabet Med; 2006 May; 23(5):510-5. PubMed ID: 16681559
    [Abstract] [Full Text] [Related]

  • 27. A direct comparison of the pharmacodynamic properties of insulin detemir and neutral protamine lispro insulin in patients with type 1 diabetes.
    Korsatko S, Glettler K, Olsen KJ, Wutte A, Bock G, Koehler G, Mader JK, Semlitsch B, Pieber TR.
    Diabetes Obes Metab; 2013 Mar; 15(3):241-5. PubMed ID: 23013357
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The addition of acarbose to insulin lispro reduces acute glycaemic responses in patients with type-2 diabetes.
    Hermanns N, Burkert A, Haak T.
    Exp Clin Endocrinol Diabetes; 2004 Jun; 112(6):310-4. PubMed ID: 15216448
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Insulinkinetic and -dynamic in diabetic patients under insulin pump therapy after injections of human insulin or the insulin analogue (B28Asp).
    Wiefels K, Hübinger A, Dannehl K, Gries FA.
    Horm Metab Res; 1995 Sep; 27(9):421-4. PubMed ID: 8557242
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A novel insulin formulation with a more rapid onset of action.
    Steiner S, Hompesch M, Pohl R, Simms P, Flacke F, Mohr T, Pfützner A, Heinemann L.
    Diabetologia; 2008 Sep; 51(9):1602-6. PubMed ID: 18641968
    [Abstract] [Full Text] [Related]

  • 37. Time-action profile of an oral enteric insulin formulation in healthy Chinese volunteers.
    Li J, Wang Y, Han L, Sun X, Yu H, Yu Y.
    Clin Ther; 2012 Dec; 34(12):2333-8. PubMed ID: 23195963
    [Abstract] [Full Text] [Related]

  • 38. Pharmacodynamics of insulin Lispro in 2 patients with type II diabetes mellitus.
    Jehle PM, Fussgänger RD, Seibold A, Lüttke B, Böhm BO.
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):498-503. PubMed ID: 8937933
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.